Modesto, A.C.F.; Silveira, E.A.; dos Santos Rodrigues, A.P.; Lima, D.M.; Provin, M.P.; Amaral, R.G.
Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial. Sci. Pharm. 2020, 88, 48.
https://doi.org/10.3390/scipharm88040048
AMA Style
Modesto ACF, Silveira EA, dos Santos Rodrigues AP, Lima DM, Provin MP, Amaral RG.
Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial. Scientia Pharmaceutica. 2020; 88(4):48.
https://doi.org/10.3390/scipharm88040048
Chicago/Turabian Style
Modesto, Ana Carolina Figueiredo, Erika Aparecida Silveira, Ana Paula dos Santos Rodrigues, Dione Marçal Lima, Mércia Pandolfo Provin, and Rita Goreti Amaral.
2020. "Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial" Scientia Pharmaceutica 88, no. 4: 48.
https://doi.org/10.3390/scipharm88040048
APA Style
Modesto, A. C. F., Silveira, E. A., dos Santos Rodrigues, A. P., Lima, D. M., Provin, M. P., & Amaral, R. G.
(2020). Prevalence of Drug Interaction in Severely Obese Individuals and Associated Factors: Baseline Results from a Clinical Trial. Scientia Pharmaceutica, 88(4), 48.
https://doi.org/10.3390/scipharm88040048
